Journal of Lipids · 2015 · 34 citations · 33 references
Life SciencesBiochemistryPathobiologyInflammationLipid BiochemistryRedox BiochemistryAntioxidant DefenseLipid MetabolismLipid OxidationLipid PeroxidationLipoprotein MetabolismOxidative Damage To BiomoleculesAntioxidant PropertiesAtherosclerotic ProgressionCholesterol EffluxLipid Peroxidation In Disease PathogenesisOxidative Damage In LipidsOxidative Stress In Cardiovascular DiseaseReverse Cholesterol TransportTyrosine Oxidation
High-density lipoprotein (HDL) has protective effects against the development of atherosclerosis; these effects include reverse cholesterol transport, antioxidant ability, and anti-inflammation. Myeloperoxidase (MPO) secreted by macrophages in atherosclerotic lesions generates tyrosyl radicals in apolipoprotein A-I (apoA-I) molecules, inducing the formation of apoA-I/apoA-II heterodimers through the tyrosine-tyrosine bond in HDL. Functional characterization of HDL oxidized by MPO could provide useful information about the significance of apoA-I/apoA-II heterodimers measurement. We investigated the effects of MPO-induced oxidation on the antiatherogenic functions of HDL as described above. The antioxidant ability of HDL, estimated as the effect on LDL oxidation induced by copper sulfate, was not significantly affected after MPO oxidation. HDL reduced THP-1 monocyte migration by suppressing the stimulation of human umbilical vein endothelial cells induced by lipopolysaccharide (LPS). MPO-oxidized HDL also showed inhibition of THP-1 chemotaxis, but the extent of inhibition was significantly attenuated compared to intact HDL. MPO treatment did not affect the cholesterol efflux capacity of HDL from [(3)H]-cholesterol-laden macrophages derived from THP-1 cells. The principal effect of MPO oxidation on the antiatherogenic potential of HDL would be the reduction of anti-inflammatory ability, suggesting that measurement of apoA-I/apoA-II heterodimers might be useful to estimate anti-inflammatory ability of HDL.
33
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Renliang Zhang · JAMA · 2001 · 923 citations
Medicine, Cardiology, Pathology +16
Lemin Zheng, Benedicta N. Nukuna, Marie-Luise Brennan et al. · Journal of Clinical Investigation · 2004 · 657 citations
Lemin Zheng, Benedicta N. Nukuna, Marie‐Luise Brennan et al. · Journal of Clinical Investigation · 2004 · 647 citations · Full text